GEF vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GEF presents a conflicting profile characterized by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health, despite trading below its intrinsic value of $71.39. While the PEG ratio (0.77) and Forward P/E (14.24) suggest potential value, the company has missed earnings estimates in four consecutive quarters with a significant average surprise of -47.31%. The high dividend payout ratio of 89.26% combined with bearish insider activity and negative revenue growth creates a precarious environment for investors. Overall, the stock is a value trap candidate unless operational efficiency improves.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
GEF vs TSLA: Head-to-Head Comparison
This page compares Greif, Inc. (GEF) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.